Related Experiment Video
Updated: Jan 27, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Topoisomerase Inhibitors and Targeted Delivery in Cancer Therapy
1Antibody Discovery and Protein Engineering, MedImmune, One MedImmune Way, Gaithersburg, MD 20878, United States.
Abstract:
DNA topoisomerases are enzymes that catalyze the alteration of DNA topology with transiently induced DNA strand breakage, essential for DNA replication. Topoisomerases are validated cancer chemotherapy targets. Anticancer agents targeting Topoisomerase I and II have been in clinical use and proven to be highly effective, though with significant side effects. There are tremendous efforts to develop new generation of topoisomerase inhibitors. Targeted delivery of topoisomerase inhibitors is another way to reduce the side effects. Conjugates of topoisomerases inhibitors with antibody, polymer, or small molecule are developed to target these inhibitors to tumor sites.
Insights
DNA topoisomerases are crucial enzymes for DNA replication and are key cancer chemotherapy targets. New inhibitors aim to improve efficacy and reduce side effects through targeted delivery strategies.
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Therapeutics
Background:
- DNA topoisomerases regulate DNA topology, essential for cellular processes like replication.
- Topoisomerases are validated targets in cancer chemotherapy, with existing drugs offering significant efficacy but notable side effects.
- Developing next-generation topoisomerase inhibitors and targeted delivery systems is a major focus in oncology.
Purpose of the Study:
- To explore the role of DNA topoisomerases as cancer targets.
- To review current and emerging strategies for topoisomerase inhibitor development.
- To highlight the potential of targeted delivery to mitigate side effects of topoisomerase inhibitors.
Main Methods:
- Review of existing literature on DNA topoisomerases and their inhibitors.
- Analysis of clinical applications and limitations of current topoisomerase-targeting drugs.
- Examination of novel strategies for targeted delivery of anticancer agents.
Main Results:
- Topoisomerase I and II inhibitors are clinically effective anticancer agents.
- Significant side effects are associated with current topoisomerase inhibitors.
- Targeted delivery approaches, including antibody and polymer conjugates, show promise for reducing toxicity.
Conclusions:
- DNA topoisomerases remain critical targets for cancer treatment.
- Advancements in inhibitor design and targeted delivery are essential for improving therapeutic outcomes.
- Targeted strategies offer a viable path to enhance the safety and efficacy of topoisomerase-based cancer therapies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Gene Therapy
Group Therapy

